Teladoc Health, Inc. (NYSE:TDOC) Receives $54.59 Consensus PT From Analysts
Teladoc Health, Inc. (NYSE:TDOC) Receives $54.59 Consensus PT From Analysts
Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) have received an average rating of "Hold" from the thirty-five analysts that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, twenty-one have issued a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $54.59.
据Marketbeat.com报道,Teladoc Health,Inc.(纽约证券交易所代码:TDOC-GET Rating)的股票得到了目前跟踪该公司的35位分析师的平均评级为持有。两名股票研究分析师对该股给予了卖出建议,21名分析师给出了持有建议,四名分析师对该公司提出了买入建议。在去年发布该股报告的券商中,平均12个月目标价为54.59美元。
Several analysts have recently commented on TDOC shares. Bank of America raised their target price on shares of Teladoc Health from $36.00 to $42.00 and gave the stock a "neutral" rating in a research note on Wednesday, July 6th. Piper Sandler reduced their price objective on shares of Teladoc Health from $42.00 to $40.00 and set an "overweight" rating for the company in a research note on Thursday, July 28th. KeyCorp assumed coverage on shares of Teladoc Health in a report on Thursday, September 15th. They set a "sector weight" rating for the company. StockNews.com upgraded shares of Teladoc Health to a "sell" rating in a report on Tuesday, August 9th. Finally, Stifel Nicolaus lowered their price target on shares of Teladoc Health from $36.00 to $30.00 in a report on Thursday, July 28th.
几位分析师最近对TDOC的股票发表了评论。7月6日周三,美国银行在一份研究报告中将Teladoc Health的目标价从36.00美元上调至42.00美元,并给予该股“中性”评级。派珀·桑德勒将Teladoc Health的股票目标价从42.00美元下调至40.00美元,并在7月28日星期四的一份研究报告中为该公司设定了“增持”评级。KeyCorp在9月15日星期四的一份报告中对Teladoc Health的股票进行了报道。他们为该公司设定了“行业权重”评级。在8月9日星期二的一份报告中,StockNews.com将Teladoc Health的股票评级上调至“卖出”。最后,Stifel Nicolaus在7月28日星期四的一份报告中将Teladoc Health的目标股价从36.00美元下调至30.00美元。
Insider Buying and Selling
内幕买卖
In related news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total value of $37,500.00. Following the transaction, the senior vice president now owns 26,408 shares in the company, valued at $990,300. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $37.50, for a total transaction of $37,500.00. Following the transaction, the senior vice president now owns 26,408 shares in the company, valued at $990,300. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Arnnon Geshuri sold 4,098 shares of the stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $34.27, for a total value of $140,438.46. Following the transaction, the insider now owns 76,182 shares in the company, valued at approximately $2,610,757.14. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 7,318 shares of company stock worth $255,321. Insiders own 1.55% of the company's stock.
在相关新闻中,高级副总裁Daniel·特伦彻在8月17日星期三的一笔交易中出售了1,000股该股。这只股票的平均售价为37.50美元,总价值为37500.00美元。交易完成后,高级副总裁现在拥有该公司26,408股股份,价值990,300美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可在这个环节。在Teladoc Health的其他新闻中,高级副总裁Daniel·特伦彻在8月17日星期三的一笔交易中出售了1,000股该股。该股以37.50美元的平均价格出售,总成交金额为37500.00美元。交易完成后,高级副总裁现在拥有该公司26,408股股份,价值990,300美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可在美国证券交易委员会网站。此外,内部人士Arnnon Geshuri在8月26日星期五的一笔交易中出售了4098股该股。这些股票的平均价格为34.27美元,总价值为140,438.46美元。交易完成后,这位内部人士现在拥有该公司76,182股,价值约2,610,757.14美元。关于这次销售的披露可以找到这里。在上个季度,内部人士出售了7,318股公司股票,价值255,321美元。内部人士持有该公司1.55%的股份。
Institutional Inflows and Outflows
机构资金流入和流出
Teladoc Health Price Performance
Teladoc健康性价比
Shares of NYSE TDOC opened at $28.00 on Friday. The company has a current ratio of 3.38, a quick ratio of 3.22 and a debt-to-equity ratio of 0.25. Teladoc Health has a twelve month low of $24.67 and a twelve month high of $156.82. The stock has a 50 day moving average of $32.86 and a two-hundred day moving average of $40.58. The stock has a market cap of $4.51 billion, a P/E ratio of -0.46 and a beta of 0.93.
上周五,纽约证交所TDOC的股价开盘报28.00美元。该公司的流动比率为3.38,速动比率为3.22,债务权益比率为0.25。Teladoc Health的12个月低点为24.67美元,12个月高位为156.82美元。该股的50日移动均线切入位为32.86美元,200日移动均线切入位为40.58美元。该股市值为45.1亿美元,市盈率为-0.46,贝塔系数为0.93。
Teladoc Health (NYSE:TDOC – Get Rating) last issued its quarterly earnings results on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share for the quarter, topping the consensus estimate of ($0.71) by $0.27. The firm had revenue of $592.38 million during the quarter, compared to the consensus estimate of $586.86 million. Teladoc Health had a negative return on equity of 2.04% and a negative net margin of 441.94%. On average, research analysts forecast that Teladoc Health will post -1.54 earnings per share for the current year.
Teladoc Health(纽约证券交易所代码:TDOC-GET Rating)最近一次发布季度收益报告是在7月27日星期三。这家医疗服务提供商公布了本季度每股收益(0.44美元),比普遍预期的(0.71美元)高出0.27美元。该公司本季度营收为5.9238亿美元,而市场普遍预期为5.8686亿美元。Teladoc Health的净资产回报率为负2.04%,净利润率为负441.94%。研究分析师平均预测,Teladoc Health本年度每股收益将达到1.54美元。
Teladoc Health Company Profile
Teladoc Health公司简介
(Get Rating)
(获取评级)
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
Teladoc Health,Inc.在美国和国际上提供虚拟医疗服务。该公司提供一系列服务和解决方案,涵盖非紧急、间歇性、慢性和复杂的医疗状况,包括糖尿病、高血压、慢性肾脏疾病、癌症、充血性心力衰竭和精神健康状况。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- Don't Give Up on These Q3 Losers
- The Anatomy of a Great Pension Plan
- 3 Safe Earnings Plays for a Risk-Off Market
- Tyson Foods Takes a Lickin' and Keeps on Tickin' Lower
- Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
- 免费获取StockNews.com关于Teladoc Health(TDOC)的研究报告
- 不要放弃这些第三季度的失败者
- 一个伟大的养老金计划的剖析
- 避险市场的三大安全收益
- 泰森食品股价下跌,继续走低
- 小盘股Catalyst Pharma是市场上价格表现最好的公司之一
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受Teladoc健康日报的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Teladoc Health和相关公司的最新新闻和分析师评级的每日简要摘要。